Literature DB >> 15198553

Aerosol generation by metered-dose inhalers containing dimethyl ether/propane inverse microemulsions.

Mark L Sommerville1, Anthony J Hickey.   

Abstract

Water soluble compounds were incorporated into metered-dose inhalers (MDIs) by using water-in-propellant lecithin microemulsions, in which dimethyl ether (DME) and propane acted as both continuous phase and propellant. Lecithin, water, and water soluble compounds were added to glass MDI containers, valves were crimped on, and propellants were added using a pressure burette. Aerosols were produced using commercially available actuators, and inertial impaction was used to determine the mass median aerodynamic diameter (MMAD), geometric standard deviation (GSD), and fine particle fraction (FPF) of the resulting aerosols. The DME/propane/lecithin microemulsion MDIs generated aerosols with particle size distributions suitable for pulmonary delivery (eg, MMAD 3.1 microm, FPF 59% for DME with lecithin content 3%, water content 2.5% [wt/wt]). Increasing water concentration (up to 8% wt/wt) was correlated with a reduction in FPF. Freezing and rewarming had no adverse effect on MMAD, GSD, or FPF. Storage of microemulsion samples for up to 3 weeks did not adversely affect the MMAD, GSD, or FPF. This approach may enable the pulmonary delivery of water soluble therapeutic agents via MDIs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15198553      PMCID: PMC2750651          DOI: 10.1208/pt040458

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  6 in total

1.  Influence of formulation on aerosol particle size.

Authors:  G P Polli; W M Grim; F A Bacher; M H Yunker
Journal:  J Pharm Sci       Date:  1969-04       Impact factor: 3.534

2.  Lecithin inverse microemulsions for the pulmonary delivery of polar compounds utilizing dimethylether and propane as propellants.

Authors:  M L Sommerville; J B Cain; C S Johnson; A J Hickey
Journal:  Pharm Dev Technol       Date:  2000       Impact factor: 3.133

Review 3.  Assessing lung deposition of inhaled medications. Consensus statement from a workshop of the British Association for Lung Research, held at the Institute of Biology, London, U.K. on 17 April 1998.

Authors:  N J Snell; D Ganderton
Journal:  Respir Med       Date:  1999-02       Impact factor: 3.415

4.  Lecithin microemulsions in dimethyl ether and propane for the generation of pharmaceutical aerosols containing polar solutes.

Authors:  Mark L Sommerville; Charles S Johnson; Judith B Cain; Franticek Rypacek; Anthony J Hickey
Journal:  Pharm Dev Technol       Date:  2002       Impact factor: 3.133

5.  Comparison of output particle size distributions from pressurized aerosols formulated as solutions or suspensions.

Authors:  R N Dalby; P R Byron
Journal:  Pharm Res       Date:  1988-01       Impact factor: 4.200

6.  Formulation and in vitro evaluation of pressurized inhalation aerosols containing isotropic systems of lecithin and water.

Authors:  R M Evans; S J Farr; N A Armstrong; S M Chatham
Journal:  Pharm Res       Date:  1991-05       Impact factor: 4.200

  6 in total
  5 in total

Review 1.  Lipid-based pulmonary delivery system: a review and future considerations of formulation strategies and limitations.

Authors:  Cheng Loong Ngan; Azren Aida Asmawi
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

2.  Development of budesonide microparticles using spray-drying technology for pulmonary administration: design, characterization, in vitro evaluation, and in vivo efficacy study.

Authors:  Sonali R Naikwade; Amrita N Bajaj; Prashant Gurav; Madhumanjiri M Gatne; Pritam Singh Soni
Journal:  AAPS PharmSciTech       Date:  2009-08-01       Impact factor: 3.246

Review 3.  Advances in metered dose inhaler technology: formulation development.

Authors:  Paul B Myrdal; Poonam Sheth; Stephen W Stein
Journal:  AAPS PharmSciTech       Date:  2014-01-23       Impact factor: 3.246

4.  Evaluation of a nanoemulsion-based formulation for respiratory delivery of budesonide by nebulizers.

Authors:  Amir Amani; Peter York; Henry Chrystyn; Brian J Clark
Journal:  AAPS PharmSciTech       Date:  2010-07-24       Impact factor: 3.246

5.  Evaluation of Aerosol Delivery of Nanosuspension for Pre-clinical Pulmonary Drug Delivery.

Authors:  Po-Chang Chiang; Jason W Alsup; Yurong Lai; Yiding Hu; Bruce R Heyde; David Tung
Journal:  Nanoscale Res Lett       Date:  2009-01-06       Impact factor: 4.703

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.